X chromosome in autoimmune diseases

Expert Review of Clinical Immunology

Volumn 4, Issue 5, 2008, Pages 591-597

  Invernizzi, Pietro ^a,b   Pasini, Simone ^a   Podda, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune disease; Autoimmunity; Epigenetic factor; Genetic factor; X chromosome; X chromosome inactivation

Indexed keywords

XENOBIOTIC AGENT;

AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CHROMOSOME LOSS; ENVIRONMENTAL FACTOR; EPIGENETICS; HEREDITY; HUMAN; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; JUVENILE RHEUMATOID ARTHRITIS; MOLECULAR MIMICRY; MONOSOMY X; MULTIPLE SCLEROSIS; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WISKOTT ALDRICH SYNDROME; X CHROMOSOME; X CHROMOSOME INACTIVATION;

EID: 77649158514     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.4.5.591     Document Type: Review

References (59)

1. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84(3), 223-243 (1997). 24 autoimmune diseases.
2. Whitacre CC. Sex differences in autoimmune disease. Nat. Immunol. 2(9), 777-780 (2001).
3. Invernizzi P, Miozzo M, Battezzati PM et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 363(9408), 533-535 (2004). (Pubitemid 38229455)
4. Invernizzi P, Miozzo M, Selmi C et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J. Immunol. 175(1), 575-578 (2005).
5. Brix TH, Knudsen GP, Kristiansen M, Kyvik KO, Orstavik KH, Hegedus L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 90(11), 5949-5953 (2005).
6. Ozcelik T, Uz E, Akyerli CB et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur. J. Hum. Genet. 14(6), 791-797 (2006).
7. Yin X, Latif R, Tomer Y, Davies TF. Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease. Ann. NY Acad. Sci. 1110, 193-200 (2007).
8. Ozbalkan Z, Bagislar S, Kiraz S et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum. 52(5), 1564-1570 (2005).
9. Uz E, Loubiere LS, Gadi VK et al. Skewed X-chromosome inactivation in scleroderma. Clin. Rev. Allergy Immunol. 34, 352-355 (2007).
10. Davis CJ, Davison RM, Payne NN, Rodeck CH, Conway GS. Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome defect: opinion. Hum. Reprod. 15(11), 2418-2422 (2000).
11. Sybert VP, McCauley E. Turner's syndrome. N. Engl. J. Med. 351(12), 1227-1238 (2004).
12. Valiaho J, Riikonen P, Vihinen M. Novel immunodeficiency data servers. Immunol. Rev. 178, 177-185 (2000).
13. Selmi C, Mayo MJ, Bach N et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127(2), 485-492 (2004).
14. Ebers GC, Bulman DE, Sadovnick AD et al. A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315(26), 1638-1642 (1986).
15. Green A. The role of genetic factors in the development of insulin-dependent diabetes mellitus. Curr. Top. Microbiol. Immunol. 164, 3-16 (1990).
16. Invernizzi P, Selmi C, Mackay IR, Podda M, Gershwin ME. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin. Gastroenterol. Hepatol. 3(5), 401-410 (2005).
17. Gorodezky C, Alaez C, Murguia A et al. HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example. Autoimmun. Rev. 5(3), 187-194 (2006).
18. Barbesino G, Tomer Y, Concepcion ES, Davies TF, Greenberg DA. Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease. J. Clin. Endocrinol. Metab. 83(9), 3290-3295 (1998).
19. Becker KG, Simon RM, Bailey-Wilson JE et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl Acad. Sci. USA 95(17), 9979-9984 (1998).
20. Oldstone MB. Molecular mimicry and autoimmune disease. Cell 50(6), 819-820 (1987).
21. Selmi C, Balkwill DL, Invernizzi P et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobioticmetabolizing bacterium. Hepatology 38(5), 1250-1257 (2003).
22. von Herrath MG, Oldstone MB. Virus-induced autoimmune disease. Curr. Opin. Immunol. 8(6), 878-885 (1996).
23. Kaplan MM. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am. J. Gastroenterol. 99(11), 2147-2149 (2004).
24. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J. 12(13), 1255-1265 (1998).
25. Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65(2), 319-331 (1991).
26. Richardson B. DNA methylation and autoimmune disease. Clin. Immunol. 109(1), 72-79 (2003).
27. Larsson K, Elding-Larsson H, Cederwall E et al. Genetic and perinatal factors as risk for childhood Type 1 diabetes. Diabetes Metab. Res. Rev. 20(6), 429-437 (2004).
28. Avner P, Heard E. X-chromosome inactivation: counting, choice and initiation. Nat. Rev. 2(1), 59-67 (2001).
29. Brown CJ, Robinson WP. The causes and consequences of random and non-random X chromosome inactivation in humans. Clin. Genet. 58(5), 353-363 (2000).
30. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434(7031), 400-404 (2005).
31. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr. 100(5), 731-737 (1982).
32. Noguchi M, Yi H, Rosenblatt HM et al. Interleukin-2 receptor g chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73(1), 147-157 (1993).
33. Gulino AV, Notarangelo LD. Hyper IgM syndromes. Curr. Opin. Rheumatol. 15(4), 422-429 (2003).
34. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78(4), 635-644 (1994).
35. Richards EJ. Inherited epigenetic variation - revisiting soft inheritance. Nat. Rev. 7(5), 395-401 (2006).
36. Lu Q, Qiu X, Hu N, Wen H, Su Y, Richardson BC. Epigenetics, disease, and therapeutic interventions. Ageing Res. Rev. 5(4), 449-467 (2006).
37. Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science 187(4173), 226-232 (1975).
38. Bestor TH. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9(16), 2395-2402 (2000).
39. Antequera F, Bird A. Number of CpG islands and genes in human and mouse. Proc. Natl Acad. Sci. USA 90(24), 11995-11999 (1993).
40. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr. Opin. Genet. Dev. 15(5), 490-495 (2005).
41. Costa FF. Non-coding RNAs, epigenetics and complexity. Gene 410(1), 9-17 (2008).
42. Bjornsson HT, Fallin MD, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 20(8), 350-358 (2004).
43. Sharp A, Robinson D, Jacobs P. Ageand tissue-specific variation of X chromosome inactivation ratios in normal women. Hum. Genet. 107(4), 343-349 (2000).
44. Chagnon P, Provost S, Belisle C, Bolduc V, Gingras M, Busque L. Age-associated skewing of X-inactivation ratios of blood cells in normal females: a candidate-gene analysis approach. Exp. Hematol. 33(10), 1209-1214 (2005).
45. Stewart JJ. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol. Today 19(8), 352-357 (1998).
46. Huang Q, Parfitt A, Grennan DM, Manolios N. X-chromosome inactivation in monozygotic twins with systemic lupus erythematosus. Autoimmunity 26(2), 85-93 (1997).
47. Chitnis S, Monteiro J, Glass D et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res. 2(5), 399-406 (2000).
48. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 33(11), 1665-1673 (1990).
49. Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol. 140(7), 2197-2200 (1988).
50. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97(9), 2063-2073 (1996).
51. Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179(9), 6352-6358 (2007).
52. Knudsen GP, Harbo HF, Smestad C et al. X chromosome inactivation in females with multiple sclerosis. Eur. J. Neurol. 14(12), 1392-1396 (2007).
53. Ozcelik T. X chromosome inactivation and female predisposition to autoimmunity. Clin. Rev. Allergy Immunol. 34(3), 348-351 (2008).
54. Miozzo M, Selmi C, Gentilin B et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 46(2), 456-462 (2007).
55. Invernizzi P, Miozzo M, Oertelt-Prigione S et al. X monosomy in female systemic lupus erythematosus. Ann. NY Acad. Sci. 1110, 84-91 (2007).
56. Milkiewicz P, Heathcote J. Can Turner syndrome teach us about the pathogenesis of chronic cholestasis? Hepatology 40(5), 1226-1228 (2004).
57. Ranke MB, Saenger P. Turner's syndrome. Lancet 358(9278), 309-314 (2001).
58. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 130(1), 25-35 (2007).
59. Hernandez-Molina G, Svyryd Y, Sanchez-Guerrero J, Mutchinick OM. The role of the X chromosome in immunity and autoimmunity. Autoimmun. Rev. 6(4), 218-222 (2007).